PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.78%
Negative net income growth while AVGO stands at 6.69%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
5.31%
D&A growth of 5.31% while AVGO is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-41.41%
Negative yoy deferred tax while AVGO stands at 354.58%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-13.92%
Negative yoy SBC while AVGO is 1.43%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
4766.67%
Slight usage while AVGO is negative at -1423.29%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
1045.00%
AR growth while AVGO is negative at -271.11%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
49.16%
Some inventory rise while AVGO is negative at -227.27%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-137.04%
Negative yoy AP while AVGO is 14.36%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
15.66%
Some yoy usage while AVGO is negative at -204.08%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
112.12%
Well above AVGO's 84.85%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-0.67%
Negative yoy CFO while AVGO is 2.31%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
23.21%
CapEx growth well above AVGO's 13.93%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-400.00%
Both yoy lines negative, with AVGO at -111.76%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
16.72%
Less growth in investment purchases vs. AVGO's 36.26%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
18.23%
Below 50% of AVGO's 108.11%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-20.00%
Both yoy lines negative, with AVGO at -758.33%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
81.64%
Investing outflow well above AVGO's 13.89%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-33.82%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-41.30%
We cut yoy buybacks while AVGO is 73.37%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.